KLCM Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,187
Closed -$324K 283
2025
Q4
$324K Sell
3,187
-800
-20% -$64.2K 0.03% 183
2025
Q3
$218K Hold
3,987
0.02% 157
2025
Q2
$212K Buy
+3,987
New +$203K 0.02% 157
2025
Q1
Sell
-3,987
Closed -$224K 177
2024
Q4
$224K Hold
3,987
0.03% 150
2024
Q3
$272K Buy
+3,987
New +$225K 0.03% 135
2024
Q2
Sell
-3,987
Closed -$275K 160
2024
Q1
$275K Hold
3,987
0.04% 132
2023
Q4
$295K Hold
3,987
0.05% 119
2023
Q3
$272K Hold
3,987
0.05% 111
2023
Q2
$374K Hold
3,987
0.07% 98
2023
Q1
$270K Buy
+3,987
New +$256K 0.05% 111

Other funds holding EXAS

KLCM Advisors's EXAS Position: Q1 2026 in Review

KLCM Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,187 shares — an estimated $324K sold.

KLCM Advisors first reported a position in EXAS in Q1 2023 and held it in 10 quarters. The position peaked at $374K in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • KLCM Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • KLCM Advisors sold 3,187 Exact Sciences shares in Q1 2026, an estimated $324K.
  • KLCM Advisors first reported a position in Exact Sciences in Q1 2023 and held it in 10 quarters.
  • KLCM Advisors's Exact Sciences position peaked at $374K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on KLCM Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.